Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

UniQure

Tracked across 14 events · 379 articles · First seen Feb 10, 2026 · Last active Apr 12, 2026

Sentiment
-49
Attention
4
Events
14
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 -90
Regulatory
UniQure is facing a class action lawsuit for allegedly misleading investors about the FDA approval likelihood of its drug candidate, AMT-130. This news caused its ordinary shares to plummet by over 49%. The company's reputation and stock price are severely negatively impacted.
Feb 10, 2026 · 7 articles
2 0
Business
UniQure will report its fourth quarter and full year 2025 financial results, which will provide investors with an update on its financial performance and operational progress. This event is a routine financial disclosure for UniQure.
Feb 23, 2026 · 8 articles
4 -80
Business
UniQure is facing a class action lawsuit due to alleged misrepresentations regarding its drug AMT-130 and its interactions with the United States===Food and Drug Administration. This led to a significant drop in its stock price.
Feb 11, 2026 · 7 articles
4 -70
Regulatory
UniQure is facing a shareholder class action lawsuit alleging false and misleading statements regarding its Pivotal Study design and the likelihood of BLA delays. This could negatively impact its stock price and reputation.
Feb 11, 2026 · 8 articles
2 -50
Business
UniQure is facing a class action lawsuit for allegedly misrepresenting and failing to disclose crucial information regarding the FDA approval status of its Pivotal Study design and the likelihood of delays in its Biologics License Application timeline. This could lead to significant financial penalties and reputational damage for UniQure.
Feb 11, 2026 · 49 articles
+ 9 more events View on Dashboard
90 UniQure failed to secure full FDA approvalUniQure Faces Class Action Lawsuit
80 UniQure made false and misleading statementsUniQure Faces Class Action Lawsuit
United States===Food and Drug Administration regulated by UniQure UniQure's gene therapy candidate is regulated by the United States===Food and Dr
NEWSDESK
Track UniQure live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.